hUC-MSC-EXs containing miR-451a can limit the EMT of hepatocellular carcinoma (HCC) cells by targeting ADAM10; this may provide a new target for HCC therapy [51]. This evidence concerns the gene ADAM10 and hepatocellular carcinoma.